Skysona is indicated to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy.
According to the Company, the premixed bags were developed to reduce preparation time and the risk of preparation errors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback